Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Lancet. 2010 Jul 17;376(9736):180-8. doi: 10.1016/S0140-6736(10)60588-0. Epub 2010 Jun 10.
Vitamin D is crucial for maintenance of musculoskeletal health, and might also have a role in extraskeletal tissues. Determinants of circulating 25-hydroxyvitamin D concentrations include sun exposure and diet, but high heritability suggests that genetic factors could also play a part. We aimed to identify common genetic variants affecting vitamin D concentrations and risk of insufficiency.
We undertook a genome-wide association study of 25-hydroxyvitamin D concentrations in 33 996 individuals of European descent from 15 cohorts. Five epidemiological cohorts were designated as discovery cohorts (n=16 125), five as in-silico replication cohorts (n=9367), and five as de-novo replication cohorts (n=8504). 25-hydroxyvitamin D concentrations were measured by radioimmunoassay, chemiluminescent assay, ELISA, or mass spectrometry. Vitamin D insufficiency was defined as concentrations lower than 75 nmol/L or 50 nmol/L. We combined results of genome-wide analyses across cohorts using Z-score-weighted meta-analysis. Genotype scores were constructed for confirmed variants.
Variants at three loci reached genome-wide significance in discovery cohorts for association with 25-hydroxyvitamin D concentrations, and were confirmed in replication cohorts: 4p12 (overall p=1.9x10(-109) for rs2282679, in GC); 11q12 (p=2.1x10(-27) for rs12785878, near DHCR7); and 11p15 (p=3.3x10(-20) for rs10741657, near CYP2R1). Variants at an additional locus (20q13, CYP24A1) were genome-wide significant in the pooled sample (p=6.0x10(-10) for rs6013897). Participants with a genotype score (combining the three confirmed variants) in the highest quartile were at increased risk of having 25-hydroxyvitamin D concentrations lower than 75 nmol/L (OR 2.47, 95% CI 2.20-2.78, p=2.3x10(-48)) or lower than 50 nmol/L (1.92, 1.70-2.16, p=1.0x10(-26)) compared with those in the lowest quartile.
Variants near genes involved in cholesterol synthesis, hydroxylation, and vitamin D transport affect vitamin D status. Genetic variation at these loci identifies individuals who have substantially raised risk of vitamin D insufficiency.
Full funding sources listed at end of paper (see Acknowledgments).
维生素 D 对维持骨骼肌肉健康至关重要,在骨骼外组织中也可能发挥作用。循环 25-羟维生素 D 浓度的决定因素包括阳光照射和饮食,但高遗传性表明遗传因素也可能起作用。我们旨在确定影响维生素 D 浓度和不足风险的常见遗传变异。
我们对来自 15 个队列的 33996 名欧洲血统个体的 25-羟维生素 D 浓度进行了全基因组关联研究。五个流行病学队列被指定为发现队列(n=16125),五个为基于模拟的复制队列(n=9367),五个为从头复制队列(n=8504)。25-羟维生素 D 浓度通过放射免疫测定法、化学发光测定法、ELISA 或质谱法测量。维生素 D 不足定义为浓度低于 75 nmol/L 或 50 nmol/L。我们使用 Z 分数加权荟萃分析合并了队列间全基因组分析的结果。为确认的变异构建了基因型评分。
在发现队列中,三个基因座的变异与 25-羟维生素 D 浓度相关,达到了全基因组显著水平,并在复制队列中得到了证实:4p12(rs2282679 总体 p=1.9x10(-109),位于 GC 中);11q12(rs12785878,靠近 DHCR7,p=2.1x10(-27));11p15(rs10741657,靠近 CYP2R1,p=3.3x10(-20))。另一个基因座(20q13,CYP24A1)在合并样本中达到了全基因组显著水平(rs6013897,p=6.0x10(-10))。基因型评分(结合三个确认的变异)最高四分位数的参与者发生 25-羟维生素 D 浓度低于 75 nmol/L(OR 2.47,95%CI 2.20-2.78,p=2.3x10(-48))或低于 50 nmol/L(1.92,1.70-2.16,p=1.0x10(-26))的风险显著增加与最低四分位数相比。
胆固醇合成、羟化和维生素 D 转运相关基因附近的变异会影响维生素 D 状态。这些基因座的遗传变异可识别出维生素 D 不足风险显著增加的个体。
文末列出了完整的资助来源(见致谢)。